Saiid Zarrabian

Part of Genesis Biotechnology Group LLC, BioBlocks, Inc. is a collaborative medicinal chemistry research organization based in San Diego, CA. The company focuses on drug discovery from initial hit through identification of development candidates. BioBlocks provides expertise and joins forces with its clients to discover compounds qualified for advancement to phase two clinical trials. Aided by a results-based lead optimization model, BioBlocks scientists have developed multiple preclinical candidates for its partners. The company's leap-to-lead platform provides an alternative source for high-quality tractable leads with multiple possible optimization pathways. The company was founded in 2002 by Peter Pallai, who has been the CEO since 2002. BioBlocks was acquired by Genesis Drug Discovery & Development LLC on October 07, 2021.

eMolecules, Inc. is a company that was founded in 2005 with the aim of reducing drug discovery timelines by improving the compound search and acquisition process. eMolecules is based in San Diego, CA, and has subsidiaries in the Netherlands and the United States. The company has created a powerful, reliable, and accurate digital chemical search engine that connects chemists to the world's largest readily available chemical space. eMolecules specializes in unique structures with dependable delivery options from a trusted network of hundreds of suppliers. The company has an extensive chemical database combined with industry-leading supply chain management, which enables the delivery of compounds quickly and reliably to chemists, allowing for the completion of more syntheses with more confidence and less time in the lab. The company was founded by Craig James and Klaus Gubernator, and the CEO is Niko Gubernator.

Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA.

La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA.

Part of Dassault Systèmes SA, SciTegic, Inc. designs, develops, and markets data analysis and mining software for the pharmaceutical and biotechnology sectors. The company is based in San Diego, CA. The company was founded by Mathew A. Hahn. SciTegic was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on September 28, 2004 for $20.95 million.

Part of AbbVie, Inc., Exemplar Pharma LLC is a company that manufactures nasal and inhalation canisters. The company is based in Fall River, MA. Exemplar Pharma was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 12, 2013 for $16.10 million.

Symbolics, Inc. manufactures artificial intelligence devices for computers. The private company is based in Burlington, MA. The company was founded by Dan Weinreb, Robert J. Werkmeister. The CEO is Bill Westerman.

Computervision Corporation is a private company that supplies electonic product definition solutions for company computer systems. The company is headquartered in Bedford, MA.